Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - A demographic study

European Journal of Cancer

Volumn 36, Issue 4, 2000, Pages 483-488

  Ringberg, A ^a   Moller T ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Accrual; Breast cancer; Ductal carcinoma in situ; Intraductal carcinoma; Randomised trial

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SIZE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 0343340387     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00289-0     Document Type: Article

References (37)

1. Andersson I. Mammographic screening for breast carcinoma. Prognostic considerations on the basis of a short-term follow-up. Acta. Radiol. Diagn. 22:1981;227-233.
2. Baker L.H. Breast Cancer Detection Demonstration Project. Five-year summary report Cancer J. Clin. 32:1982;194-225.
3. Tabár L., Gad A., Holmberg L.H.et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet. i:1985;829-832.
4. Millis R.R., Thynne G.S.J. In situ intraduct carcinoma of the breast. a long term follow-up study Br. J. Surg. 62:1975;957-962.
5. Carter D., Smith R.R.L. Carcinoma in situ of the breast. Cancer. 40:1977;1189-1193.
6. Sunshine J.A., Moseley H.S., Fletcher W.S., Krippaehne W.W. Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. Am. J. Surg. 150:1985;44-51.
7. Betsill W.L., Rosen P.P., Lieberman P.H., Robbins G.F. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. J. Am. Med. Assoc. 239:1978;1863-1867.
8. Rosen P.P., Braun D.W., Kinne D.E. The clinical significance of pre-invasive breast carcinoma. Cancer. 46:1980;919-925.
9. Page D.L., Dupont W.D., Rogers L.W., Landenberger M. Intraductal carcinoma of the breast. follow-up after biopsy only Cancer. 49:1982;751-758.
10. Fisher E.R., Sass R., Fisher B., Wickerham L., Paik S.M. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 57:1986;197-208.
11. Lagios M.D., Margolin F.R., Westdahl P.R., Rose M.R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 63:1989;618-624.
12. Arnesson L.G., Smeds S., Fagerberg G., Gröntoft O. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br. J. Surg. 76:1989;672-675.
13. Gallagher W.J., Koerner F.C., Wood W.C. Treatment of intraductal carcinoma with limited surgery. long-term follow-up J. Clin. Oncol. 7:1989;376-380.
14. Carpenter R., Boulter P.S., Cooke T., Gibbs N.M. Management of screen detected ductal carcinoma in situ of the female breast. Br. J. Surg. 76:1989;564-567.
15. Price P., Sinnett H.D., Gusterson B., Walsh G., A'Hern R.P., McKinna J.A. Duct carcinoma in situ. predictors of local recurrence and progression in patients treated by surgery alone Br. J. Cancer. 61:1990;869-872.
16. Silverstein M.J., Waisman J.R., Gamagami P.et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer. 66:1990;102-108.
17. Baird R.M., Worth A., Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am. J. Surg. 159:1990;479-481.
18. Ciatto S., Grazzini G., Iossa A.et al. In situ ductal carcinoma of the breast - analysis of clinical presentation and outcome in 156 consecutive cases. Eur. J. Surg. Oncol. 16:1990;220-224.
19. Vrouenraets B.C., Peterse J.L., van Dongen J.A. Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases. Neth. J. Surg. 43:1991;51-55.
20. Graham M.D., Lakhani S., Gazet J.C. Breast conserving surgery in the management of in situ breast carcinoma. Eur. J. Surg. Oncol. 17:1991;258-264.
21. Graversen HP, Blichert-Toft M, Andersen J, Andersen KW. Breast conservation therapy (BCT) of in situ carcinoma. In Schueren E van der, ed. 5th Breast Cancer Working Conference. Leuven, Belgium, EORTC, 1991, A66.
22. Ringberg Hagberg A. In situ carcinoma of the breast. Aspects on natural history and treatment with special reference to subcutaneous mastectomy. Doctoral dissertation, Lund University, Malmö, 1992.
23. Solin L.J., Kurtz J., Fourquet A.et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J. Clin. Oncol. 14:1996;754-763.
24. Cutuli B., Teissier E., Piat J-M.et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur. J. Cancer. 28:1992;649-654.
25. van Dongen J.A., Holland R., Peterse J.L.et al. Ductal carcinoma in situ of the breast; second EORTC consensus meeting. Eur. J. Cancer. 28A:1992;626-629.
26. Fisher B., Costantino J., Redmond C.et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med. 328:1993;1581-1586.
27. Garne J.P., Aspegren K., Möller T. Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1961-1970. Acta. Oncol. 29:1990;125-128.
28. Rutqvist L.E., Wallgren A. Inconsistencies in breast carcinoma registration. An investigation of 855 cases reported to the Swedish Cancer Registry. Acta. Radiat. Oncol. 22:1983;109-112.
29. Holland R., Hendriks J.H.C.L., Verbeek A.L.M., Mravunac M., Schuurmans Stekhoven J.H. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 335:1990;519-522.
30. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer. 40:1977;1726-1734.
31. Lagios M.D., Westdahl P.R., Margolin F.R., Rose M.R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and shortterm treatment failures. Cancer. 50:1982;1309-1314.
32. Silverstein M.J., Lagios M.D., Craig P.H.et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 77:1996;2267-2274.
33. Bondeson L., Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn. Cytopathol. 17:1997;315-320.
34. Twelves C.J., Thomson C.S., Young J., Gould A. for The Scottish Breast Cancer Focus Group, Scottish Cancer Therapy Network. Entry into clinical trials in breast cancer. the importance of specialist teams Eur. J. Cancer. 34:1998;1004-1007.
35. Fentiman I.S., Julien J.P., van Dongen J.A., van Geel B., Chetty U., Coibion M. Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853). Eur. J. Cancer. 27A:1991;450-452.
36. Bijker N, Peterse JL, Rutgers EJTh, Julien JP, Cataliotti L, Mauriac L. The selection of patients with DCIS for a clinical randomised trial: differences between large participating centres. Abstract: 7th EORTC Working Conference, Bordeaux, September 1996, p. 38.
37. Fisher B., Dignam J., Wolmark N.et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol. 16:1998;441-452.